Therapeutic Advances in MicroRNA Targeting

scientific article published on January 1, 2011

Therapeutic Advances in MicroRNA Targeting is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/FJC.0B013E3181F603D0
P953full work available at URLhttp://journals.lww.com/00005344-201101000-00001
P698PubMed publication ID20729755

P2093author name stringEva van Rooij
Rusty L. Montgomery
P2860cites workMicroRNAs as targets for antisense-based therapeuticsQ37032639
Heart failureQ53998058
Heart failureQ73397364
The nuclear RNase III Drosha initiates microRNA processingQ24295234
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAsQ24302072
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencingQ24306121
The Microprocessor complex mediates the genesis of microRNAsQ24312976
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAsQ24537328
MicroRNA genes are transcribed by RNA polymerase IIQ24562649
miR-9 and NFATc3 regulate myocardin in cardiac hypertrophyQ24598242
MicroRNAs: target recognition and regulatory functionsQ24609584
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liverQ24649633
MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genesQ24650009
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowthsQ24653709
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer modelQ24655262
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failureQ27691424
Asymmetry in the assembly of the RNAi enzyme complexQ27860763
Silencing of microRNAs in vivo with 'antagomirs'Q27860891
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Q27860893
Processing of primary microRNAs by the Microprocessor complexQ27860986
Functional siRNAs and miRNAs Exhibit Strand BiasQ27861038
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34Q28285980
MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasisQ28509140
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblastsQ28511032
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infectionQ29615959
LNA-mediated microRNA silencing in non-human primatesQ29615962
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cellsQ29616080
MicroRNA-133 controls cardiac hypertrophyQ29616572
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisQ29619873
MicroRNAs add a new dimension to cardiovascular diseaseQ33761132
2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugationQ33916133
miR-33 links SREBP-2 induction to repression of sterol transportersQ33981907
Clinical practice. Systolic heart failure.Q34093912
Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinomaQ34119365
Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?Q34455538
Small-molecule inhibitors of microrna miR-21 functionQ36192700
2'-Modified oligonucleotides for antisense therapeuticsQ36789789
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmicroRNAQ310899
P304page(s)1-7
P577publication date2011-01-01
P1433published inJournal of Cardiovascular PharmacologyQ2125808
P1476titleTherapeutic advances in MicroRNA targeting
Therapeutic Advances in MicroRNA Targeting
P478volume57

Reverse relations

cites work (P2860)
Q34059809Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
Q37723852Can exercise teach us how to treat heart disease?
Q54976146Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise.
Q35735278Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
Q38085345Function and fate of myofibroblasts after myocardial infarction
Q36025533Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction
Q34292584Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice
Q35206513Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury
Q39351982Interfering nanoparticles for silencing microRNAs
Q38954524MiR-146a/b: a family with shared seeds and different roots.
Q38679814MicroRNA in the Diseased Pulmonary Vasculature: Implications for the Basic Scientist and Clinician.
Q36849434MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6
Q34145885MicroRNA-708 regulates CD38 expression through signaling pathways JNK MAP kinase and PTEN/AKT in human airway smooth muscle cells
Q38267957MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.
Q51793583MicroRNAs in liver disease.
Q37584292Prospects of miRNA-based therapy for pancreatic cancer
Q33827444Roles of lncRNAs in pancreatic beta cell identity and diabetes susceptibility.
Q29039090Silencing disease genes in the laboratory and the clinic
Q38285749Strategies to antagonize miRNA functions in vitro and in vivo
Q35966911The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders
Q38103313The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?

Search more.